BTRC and cancer: Importantly, as different molecular pathways—such as the MAPKs, GSK3β, βTRCP, PI3K, AKT pathway—regulate NRF2 expression in cancer cells, future investigations are needed to elucidate the main mechanism involved in NRF2 availability in GBM.